Vivera BioSciences is focused on developing a selection of non-addictive drugs for indications including cardiovascular conditions and central nervous system and fluency disorders. The division pipeline centers around the utilization of TABMELT®, the patient-centric drug delivery alternative for oral and injectable medications. TABMELT® is a sublingual drug delivery system that allows patients to take medicines in seconds by dissolving them under the tongue.


Visit to learn more.